Eric Carter

Eric G.
Carter currently works at AEON Biopharma Sub, Inc., as Non-Executive Director from 2023, Visgenx, Inc., as Director from 2022, and AEON Biopharma, Inc., as Independent Director from 2023.
Dr. Carter also formerly worked at Bioniz Therapeutics, Inc., as Director from 2016 to 2022, Adverum Biotechnologies, Inc., as Independent Director from 2017 to 2021, Allergan, Inc., as Chief Medical Officer & Senior Vice President from 2011 to 2015, KP Pharmaceuticals LLC, as Chief Scientific & Medical Officer from 2009 to 2011, GSK Plc, as Vice President & Global Head from 1999 to 2009, Lundbeck Seattle BioPharmaceuticals, Inc., as Chief Medical Officer from 2018 to 2019, The University of North Carolina at Charlotte, as Associate Professor, and IACTA Pharmaceuticals, Inc., as Chief Marketing Officer.
Dr. Carter received his doctorate degree from the University of Cambridge, undergraduate degree from the University of London, doctorate degree from the University of Miami, and doctorate degree from The University of Miami Leonard M.
Miller School of Medicine.